GlassScriptPhysician profile
Troy D Davis
NPI 1871565085
$2,577.06
in general payments reported to CMS, 2019-2025
27 companies · $918 in 2025
The $918 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $196 · 2021: $188 · 2022: $525 · 2023: $262 · 2024: $385 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $504.60 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $365.21 | 2021-2025 | Qulipta, Vraylar |
| Novo Nordisk INC | $203.20 | 2019-2023 | Ozempic |
| Glaxosmithkline, LLC. | $178.46 | 2021-2024 | Trelegy Ellipta |
| Pfizer INC. | $167.07 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $149.43 | 2019-2022 | |
| Smith+Nephew, INC. | $119.56 | 2024-2025 | Grafix Pl |
| Exact Sciences Corporation | $104.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $93.37 | 2022-2023 | |
| Ets Wound Care LLC | $86.18 | 2025 | Mirragen Advanced Wound Matrix |
| Lilly USA, LLC | $69.78 | 2022 | |
| Organogenesis INC. | $68.59 | 2023-2025 | Apligraf, Puraply |
| Endologix LLC | $57.49 | 2024 | Endocross Device, Torus Stent Graft System |
| Solventum Corporation | $54.28 | 2024 | Activ.A.C., 3m Cavilon |
| Amgen INC. | $43.47 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $39.17 | 2021-2022 | |
| Convatec INC. | $37.05 | 2025 | |
| Avanir Pharmaceuticals, INC. | $35.24 | 2022 | |
| Tactile Systems Technology INC | $35.22 | 2024 | Entre Plus, Flexitouch Plus |
| E.R. Squibb & Sons, L.L.C. | $33.94 | 2022 | |
| Dexcom, INC. | $33.77 | 2021-2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.92 | 2022 | |
| Integra Lifesciences Corporation | $18.91 | 2022 | |
| Phadia US INC. | $14.11 | 2020 | |
| Astellas Pharma US INC | $14.02 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.75 | 2023 | |
| Reprise Biomedical, INC. | $12.44 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.